Mpox re-emerges: Historical background, symptom overview, and contemporary treatment options

David Banji , Otilia J F Banji

›› 2024, Vol. 13 ›› Issue (4) : 127 -134.

PDF (372KB)
›› 2024, Vol. 13 ›› Issue (4) :127 -134. DOI: 10.4103/jad.jad_91_24
Review Article
research-article
Mpox re-emerges: Historical background, symptom overview, and contemporary treatment options
Author information +
History +
PDF (372KB)

Abstract

As the global community continues to recover from the COVID-19 pandemic, the World Health Organization has issued a warning of another viral infection, mpox (monkeypox), that can pose a significant threat to public health. Mpox was once endemic in Africa but has spread globally, prompting the World Health Organization to declare it a public health emergency. In response, healthcare personnel must initiate timely, decisive, and robust action before the infection escalates. Moreover, accurate diagnosis is crucial, given the similarity between mpox and other rash-causing infections. This article provides a comprehensive overview of the symptoms, differentiating it from similar diseases, risk assessment, and treatment strategies. In addition, it aims to educate healthcare personnel with the necessary knowledge to educate others and take preventative measures when handling cases, thereby avoiding the spread of infection.

Keywords

Mpox / Orthopoxvirus / Clade / Lymphadenopathy

Cite this article

Download citation ▾
David Banji, Otilia J F Banji. Mpox re-emerges: Historical background, symptom overview, and contemporary treatment options. , 2024, 13 (4) : 127-134 DOI:10.4103/jad.jad_91_24

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Billioux BJ, Mbaya OT, Sejvar J, Nath A. Neurologic complications of smallpox and monkeypox: A review. JAMA Neurol 2022; 79(11): 1180-1186.

[2]

European Centre for Disease Prevention and Control. Risk assessment for the EU/EEA of the mpox epidemic caused by monkeypox virus clade I in affected African countries. [Online] Available from: chrome—extension://efaidnbmnnnibpcajpcglclefindmkaj/ https://www.ecdc.europa.eu/sites/default/files/documents/mpox-risk-assessment-monkeypox-virus-africa-august-2024.pdf [Accessed on August 20, 2024].

[3]

Mitjà O, Ogoina D, Titanji BK, Galvan C, Muyembe JJ, Marks M, et al. Monkeypox. Lancet 2023; 401(10370): 60-74.

[4]

Likos AM, Sammons SA, Olson VA, Frace AM, Li Y, Olsen—Rasmussen M, et al. A tale of two clades: monkeypox viruses. J Gen Virol 2005; 86(10): 2661-2672.

[5]

Howell JC, Chun E, Farrell AN, Hur EY, Caroti CM, Iuvone PM, et al. Global microRNA expression profiling: curcumin (diferuloylmethane) alters oxidative stress—responsive microRNAs in human ARPE—19 cells. Mol Vis 2013; 19: 544-560.

[6]

Cadmus S, Akinseye V, Besong M, Olanipekun T, Fadele J, Cadmus E, et al. Dynamics of Mpox infection in Nigeria: A systematic review and meta—analysis. Sci Rep 2024; 14(1): 7368.

[7]

Farahat RA, Ali I, Al—Ahdal T, Benmelouka AY, Albakri K, El—Sakka AA, et al. Monkeypox and human transmission: Are we on the verge of another pandemic? Travel Med Infect Dis 2022; 49: 102387.

[8]

World Health Organisation. Training to build community capacity to meaningfully engage in mpox response. [Online] Available from: https://www.who.int/news/item/13-06-2023-training-to-build-community-capacity-to-meaningfully-engage-in-mpox-response [Accessed on August 12, 2024].

[9]

World Health Organisation. WHO Director—General declares mpox outbreak a public health emergency of international concern. [Online] Available from: https://www.who.int/news/item/14-08-2024-who-director-general-declares-mpox-outbreak-a-public-health-emergency-of-international-concern [Accessed on August 16, 2024].

[10]

Rampogu S, Kim Y, Kim S—W, Lee KW. An overview on monkeypox virus: Pathogenesis, transmission, host interaction and therapeutics. Front Cell Infect Microbiol 2023; 13: 1076251.

[11]

Tiee MS, Harrigan RJ, Thomassen HA, Smith TB. Ghosts of infections past: using archival samples to understand a century of monkeypox virus prevalence among host communities across space and time. R Soc Open Sci 2018; 5(1): 171089.

[12]

World Health Organisation. Multi—country monkeypox outbreak: situation update. [Online] Available from: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON396 [Accessed on August 15, 2024].

[13]

Vaughan AM, Cenciarelli O, Colombe S, Alves de Sousa L, Fischer N, Gossner CM, et al. A large multi—country outbreak of monkeypox across 41 countries in the WHO European Region, March 7 to August 23 2022. Euro Surveill 2022; 27(36): 2200620.

[14]

World Health Organisation. Multi—country monkeypox outbreak in non—endemic countries: Update. [Online] Available from: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON388 [Accessed on August 15, 2024].

[15]

Abu—Hammad O, Abu—Hammad A, Jaber A—R, Jaber AR, Dar—Odeh N. Factors associated with geographic variations in the 2022 monkeypox outbreak; A systematic review. New Microb New Infec 2023; 51: 101078.

[16]

World Health Organisation. Surveillance, case investigation and contact tracing for mpox (monkeypox): Interim guidance. [Online] Available from: https://www.who.int/publications/i/item/WHO-MPX-Surveillance-2024.1 [Accessed on August 16, 2024].

[17]

Iñigo Martínez J, Gil Montalbán E, Jiménez Bueno S, Martín Martínez F, Nieto Juliá A, Sánchez Díaz J, et al. Monkeypox outbreak predominantly affecting men who have sex with men, Madrid, Spain, April 26 to June 16 2022. Euro Surveill 2022; 27(27): 2200471.

[18]

Allan—Blitz L—T, Klausner JD. Current evidence demonstrates that monkeypox is a sexually transmitted infection. Sex Transm Dis 2023; 50(2): 63-65.

[19]

Centers for Disease Control and Prevention. Mpox monitoring and risk assessment for persons exposed in the community. [Online] Available from: https://www.cdc.gov/poxvirus/mpox/clinicians/monitoring.html [Accessed on August 16, 2024].

[20]

Kaler J, Hussain A, Flores G, Kheiri S, Desrosiers D. Monkeypox: A comprehensive review of transmission, pathogenesis, and manifestation. Cureus 2022; 14(7): e26531.

[21]

Lum F—M, Torres—Ruesta A, Tay MZ, Lin RTP, Lye DC, Rénia L, et al. Monkeypox: disease epidemiology, host immunity and clinical interventions. Nat Rev Immunol 2022; 22(10): 597-613.

[22]

Dashraath P, Alves MP, Schwartz DA, Nielsen—Saines K, Baud D. Potential mechanisms of intrauterine transmission of monkeypox virus. Lancet Microbe 2023; 4(1): e14.

[23]

Vusirikala A, Charles H, Balasegaram S, Macdonald N, Kumar D, Barker—Burnside C, et al. Epidemiology of early monkeypox virus transmission in sexual networks of gay and bisexual men, England, 2022. Emerg Infect Dis 2022; 28(10): 2082-2086.

[24]

Harapan H, Ophinni Y, Megawati D, Frediansyah A, Mamada SS, Salampe M, et al. Monkeypox: A comprehensive review. Viruses 2022; 14(10): 2155.

[25]

Khattak S, Rauf MA, Ali Y, Yousaf MT, Liu Z, Wu DD, et al. The monkeypox diagnosis, treatments and prevention: A review. Front Cell Infect Microbiol 2022; 12: 1088471.

[26]

Reynolds MG, Yorita KL, Kuehnert MJ, Davidson WB, Huhn GD, Holman RC, et al. Clinical manifestations of human monkeypox influenced by route of infection. J Infect Dis 2006; 194(6): 773-780.

[27]

Messina MD, Wolf EL, Kanmaniraja D, Alpert PL, Ricci ZJ. Imaging features of anorectal proctitis in monkeypox infection. Clin Imaging 2022; 92: 109-111.

[28]

Silva S, Kohl A, Pena L, Pardee K. Clinical and laboratory diagnosis of monkeypox (mpox): Current status and future directions. iScience 2023; 26(6): 106759.

[29]

Schuele L, Masirika LM, Udahemuka JC, Siangoli FB, Mbiribindi JB, Ndishimye P, et al. Real—time PCR assay to detect the novel Clade Ib monkeypox virus, September 2023 to May 2024. Euro Surveill 2024; 29(32): 2400486.

[30]

Mailhe M, Beaumont A—L, Thy M, Le Pluart D, Perrineau S, Houhou—Fidouh N, et al. Clinical characteristics of ambulatory and hospitalised patients with monkeypox virus infection: An observational cohort study. Clin Microbiol Infect 2023; 29(2): 233-239.

[31]

Simadibrata DM, Lesmana E, Pratama MIA, Annisa NG, Thenedi K, Simadibrata M. Gastrointestinal symptoms of monkeypox infection: A systematic review and meta—analysis. J Med Virol 2023; 95(4): e28709.

[32]

Hughes C, McCollum A, Pukuta E, Karhemere S, Nguete B, Lushima R, et al. Ocular complications associated with acute monkeypox virus infection, DRC. Int J Infect Dis 2014; 21: 276-277.

[33]

Abdelaal A, Serhan HA, Mahmoud MA, Rodriguez—Morales AJ, Sah R. Ophthalmic manifestations of monkeypox virus. Eye 2023; 37(3): 383-385.

[34]

Moody S, Lamb T, Jackson E, Beech A, Malik N, Johnson L, et al. Assessment and management of secondary bacterial infections complicating Mpox (Monkeypox) using a telemedicine service: A prospective cohort study. Int J STD AIDS 2023; 34(7): 434-438.

[35]

Ortiz—Martínez Y, Montalvo—Campana M, Saul Z, Gopalratnam K, Wolff AJ, Rodríguez—Morales AJ. Respiratory manifestations and complications of monkeypox. Int J Mycobact 2023; 12(3): 367-368.

[36]

Taj S, Austin C, Hussain A, Babar MS, Sanekommu H, Imburgio S, et al. Severe gastrointestinal hemorrhage due to monkeypox virus—associated proctocolitis. Case Rep Gastrointest Med 2023; 2023(1): 9981631.

[37]

Aldred B, Lyles RH, Scott JY, Gromer DJ, Aldredge A, Workowski KA, et al. Early Tecovirimat treatment for mpox disease among people with HIV. JAMA Intern Med 2024; 184(3): 275-279.

[38]

De Clercq E, Jiang Y, Li G. Therapeutic strategies for human poxvirus infections: Monkeypox (mpox), smallpox, molluscipox, and orf. Travel Med Infect Dis 2023; 52: 102528.

[39]

Siegrist EA, Sassine J. Antivirals with activity against Mpox: A clinically oriented review. Clin Infect Dis 2023; 76(1): 155-164.

[40]

Centers for Disease Control and Prevention Prevention. Mpox treatment information for healthcare professionals. [Online] Available from: https://www.cdc.gov/poxvirus/mpox/clinicians/treatment.html [Accessed on August 17, 2024].

[41]

Centers for Disease Control and Prevention Prevention. If you're a close contact. [Online] Available from: https://www.cdc.gov/poxvirus/mpox/prevention/close-contact.html [Accessed on August 15, 2024].

[42]

Hossain AD, Jarolimova J, Elnaiem A, Huang CX, Richterman A, Ivers LC. Effectiveness of contact tracing in the control of infectious diseases: a systematic review. Lancet Public Health 2022; 7(3): e259-e273.

PDF (372KB)

72

Accesses

0

Citation

Detail

Sections
Recommended

/